Docosahexaenoic acid inhibits Helicobacter pylori growth in vitro and mice gastric mucosa colonization. 2012

Marta Correia, and Valérie Michel, and António A Matos, and Patrícia Carvalho, and Maria J Oliveira, and Rui M Ferreira, and Marie-Agnès Dillies, and Michel Huerre, and Raquel Seruca, and Ceu Figueiredo, and Jose C Machado, and Eliette Touati
Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal.

H. pylori drug-resistant strains and non-compliance to therapy are the major causes of H. pylori eradication failure. For some bacterial species it has been demonstrated that fatty acids have a growth inhibitory effect. Our main aim was to assess the ability of docosahexaenoic acid (DHA) to inhibit H. pylori growth both in vitro and in a mouse model. The effectiveness of standard therapy (ST) in combination with DHA on H. pylori eradication and recurrence prevention success was also investigated. The effects of DHA on H. pylori growth were analyzed in an in vitro dose-response study and n in vivo model. We analized the ability of H. pylori to colonize mice gastric mucosa following DHA, ST or a combination of both treatments. Our data demonstrate that DHA decreases H. pylori growth in vitro in a dose-dependent manner. Furthermore, DHA inhibits H. pylori gastric colonization in vivo as well as decreases mouse gastric mucosa inflammation. Addition of DHA to ST was also associated with lower H. pylori infection recurrence in the mouse model. In conclusion, DHA is an inhibitor of H. pylori growth and its ability to colonize mouse stomach. DHA treatment is also associated with a lower recurrence of H. pylori infection in combination with ST. These observations pave the way to consider DHA as an adjunct agent in H. pylori eradication treatment.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D004281 Docosahexaenoic Acids C22-unsaturated fatty acids found predominantly in FISH OILS. Docosahexaenoate,Docosahexaenoic Acid,Docosahexenoic Acids,Docosahexaenoic Acid (All-Z Isomer),Docosahexaenoic Acid Dimer (All-Z Isomer),Docosahexaenoic Acid, 3,6,9,12,15,18-Isomer,Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer),Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cerium Salt,Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cesium Salt,Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Potassium Salt,Docosahexaenoic Acid, 4,7,10,13,16,19-(Z,Z,Z,Z,Z,E-Isomer),Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer,Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer, Sodium Salt,Docosahexaenoic Acid, Sodium Salt,Acid, Docosahexaenoic,Acids, Docosahexaenoic,Acids, Docosahexenoic
D005753 Gastric Mucosa Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones. Cardiac Glands,Gastric Glands,Pyloric Glands,Cardiac Gland,Gastric Gland,Gastric Mucosas,Gland, Cardiac,Gland, Gastric,Gland, Pyloric,Glands, Cardiac,Glands, Gastric,Glands, Pyloric,Mucosa, Gastric,Mucosas, Gastric,Pyloric Gland
D005756 Gastritis Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders. Gastritides
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D016480 Helicobacter pylori A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405). Campylobacter pylori,Campylobacter pylori subsp. pylori,Campylobacter pyloridis,Helicobacter nemestrinae
D016481 Helicobacter Infections Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease. Infections, Helicobacter,Helicobacter Infection,Infection, Helicobacter
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Marta Correia, and Valérie Michel, and António A Matos, and Patrícia Carvalho, and Maria J Oliveira, and Rui M Ferreira, and Marie-Agnès Dillies, and Michel Huerre, and Raquel Seruca, and Ceu Figueiredo, and Jose C Machado, and Eliette Touati
January 2008, Scandinavian journal of gastroenterology,
Marta Correia, and Valérie Michel, and António A Matos, and Patrícia Carvalho, and Maria J Oliveira, and Rui M Ferreira, and Marie-Agnès Dillies, and Michel Huerre, and Raquel Seruca, and Ceu Figueiredo, and Jose C Machado, and Eliette Touati
January 2022, Frontiers in microbiology,
Marta Correia, and Valérie Michel, and António A Matos, and Patrícia Carvalho, and Maria J Oliveira, and Rui M Ferreira, and Marie-Agnès Dillies, and Michel Huerre, and Raquel Seruca, and Ceu Figueiredo, and Jose C Machado, and Eliette Touati
April 2001, Journal of gastroenterology and hepatology,
Marta Correia, and Valérie Michel, and António A Matos, and Patrícia Carvalho, and Maria J Oliveira, and Rui M Ferreira, and Marie-Agnès Dillies, and Michel Huerre, and Raquel Seruca, and Ceu Figueiredo, and Jose C Machado, and Eliette Touati
November 1991, Zeitschrift fur Gastroenterologie,
Marta Correia, and Valérie Michel, and António A Matos, and Patrícia Carvalho, and Maria J Oliveira, and Rui M Ferreira, and Marie-Agnès Dillies, and Michel Huerre, and Raquel Seruca, and Ceu Figueiredo, and Jose C Machado, and Eliette Touati
January 1991, Microbiology and immunology,
Marta Correia, and Valérie Michel, and António A Matos, and Patrícia Carvalho, and Maria J Oliveira, and Rui M Ferreira, and Marie-Agnès Dillies, and Michel Huerre, and Raquel Seruca, and Ceu Figueiredo, and Jose C Machado, and Eliette Touati
July 2010, Gut,
Marta Correia, and Valérie Michel, and António A Matos, and Patrícia Carvalho, and Maria J Oliveira, and Rui M Ferreira, and Marie-Agnès Dillies, and Michel Huerre, and Raquel Seruca, and Ceu Figueiredo, and Jose C Machado, and Eliette Touati
February 1993, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Marta Correia, and Valérie Michel, and António A Matos, and Patrícia Carvalho, and Maria J Oliveira, and Rui M Ferreira, and Marie-Agnès Dillies, and Michel Huerre, and Raquel Seruca, and Ceu Figueiredo, and Jose C Machado, and Eliette Touati
April 1996, Alimentary pharmacology & therapeutics,
Marta Correia, and Valérie Michel, and António A Matos, and Patrícia Carvalho, and Maria J Oliveira, and Rui M Ferreira, and Marie-Agnès Dillies, and Michel Huerre, and Raquel Seruca, and Ceu Figueiredo, and Jose C Machado, and Eliette Touati
March 1999, Molecular microbiology,
Marta Correia, and Valérie Michel, and António A Matos, and Patrícia Carvalho, and Maria J Oliveira, and Rui M Ferreira, and Marie-Agnès Dillies, and Michel Huerre, and Raquel Seruca, and Ceu Figueiredo, and Jose C Machado, and Eliette Touati
June 1995, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!